Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1971-2-10
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
555-66
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:5399547-Animals,
pubmed-meshheading:5399547-Blood Pressure,
pubmed-meshheading:5399547-Chemoreceptor Cells,
pubmed-meshheading:5399547-Dogs,
pubmed-meshheading:5399547-Electrophysiology,
pubmed-meshheading:5399547-Piperazines,
pubmed-meshheading:5399547-Stimulation, Chemical,
pubmed-meshheading:5399547-Sympathetic Nervous System
|
pubmed:articleTitle |
[New pharmacological method of treatment of peripheral arteritis. II. Mechanism of action of ET 495: 1-(2"-pyrimidyl)-4-(3',4'-methylenedioxybenzyl)piperazine].
|
pubmed:publicationType |
Journal Article
|